Loading ...

HER2 siRNA-loaded trastuzumab-conjugated PEG/PEI-modified mesoporous silica nanoparticles

Based on

1 Articles
2015 Most recent source

Composition

1

trastuzumab-conjugated PEG/PEI-modified mesoporous silica nanoparticles

trastuzumab-conjugated PEG-PEI-MSNP
Type Nano Material
Formula
Role carriers
2

human epidermal growth factor receptor 2 small interfering RNA

HER2 siRNA
Type Biomolecule
Formula
Role loaded material

Properties

Applications

Area Application Nanomaterial Variant Source
medicine/veterinary

More information/entries available to subscribers only.

Or, view sample content

Characterization

Biological effects

Biological system Test details Nanomaterial Variant Source
human breast cancer BT474 cell line

More information/entries available to subscribers only.

Or, view sample content

Preparation

Method 1

Type: Physical formation
Source:
Starting materials
  1. dkQZM9YWex2zyCah
  2. isH
Product

HER2 siRNA-loaded trastuzumab-conjugated PEG/PEI-modified mesoporous silica nanoparticles

Size: not specified

Medium: phosphate buffer solution

Support: none

Method 2

Type: Physical formation
Source:
Starting materials
  1. bgula6LGL74a6hPb
  2. GeJ
Product

HER2 siRNA-loaded trastuzumab-conjugated PEG/PEI-modified mesoporous silica nanoparticles

Size: not specified

Medium: phosphate buffer solution

Support: none

Method 3

Type: Physical formation
Source:
Starting materials
  1. 58qkVO3rAtPPbS1i
  2. T1V
Product

HER2 siRNA-loaded trastuzumab-conjugated PEG/PEI-modified mesoporous silica nanoparticles

Size: not specified

Medium: phosphate buffer solution

Support: none

References

Full content is available to subscribers only

To view content please choose from the following:

We use cookies to improve your experience with our site. More information

Sign up for a free trial